Literature DB >> 19815545

G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation.

Yoon Namkung1, Concetta Dipace, Eneko Urizar, Jonathan A Javitch, David R Sibley.   

Abstract

We investigated the regulatory effects of GRK2 on D(2) dopamine receptor signaling and found that this kinase inhibits both receptor expression and functional signaling in a phosphorylation-independent manner, apparently through different mechanisms. Overexpression of GRK2 was found to suppress receptor expression at the cell surface and enhance agonist-induced internalization, whereas short interfering RNA knockdown of endogenous GRK2 led to an increase in cell surface receptor expression and decreased agonist-mediated endocytosis. These effects were not due to GRK2-mediated phosphorylation of the D(2) receptor as a phosphorylation-null receptor mutant was regulated similarly, and overexpression of a catalytically inactive mutant of GRK2 produced the same effects. The suppression of receptor expression is correlated with constitutive association of GRK2 with the receptor complex as we found that GRK2 and several of its mutants were able to co-immunoprecipitate with the D(2) receptor. Agonist pretreatment did not enhance the ability of GRK2 to co-immunoprecipitate with the receptor. We also found that overexpression of GRK2 attenuated the functional coupling of the D(2) receptor and that this activity required the kinase activity of GRK2 but did not involve receptor phosphorylation, thus suggesting the involvement of an additional GRK2 substrate. Interestingly, we found that the suppression of functional signaling also required the G betagamma binding activity of GRK2 but did not involve the GRK2 N-terminal RH domain. Our results suggest a novel mechanism by which GRK2 negatively regulates G protein-coupled receptor signaling in a manner that is independent of receptor phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815545      PMCID: PMC2797181          DOI: 10.1074/jbc.M109.055707

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Regulation of receptor trafficking by GRKs and arrestins.

Authors:  Catherine A C Moore; Shawn K Milano; Jeffrey L Benovic
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

Review 2.  Phosphorylation-independent attenuation of GPCR signalling.

Authors:  Stephen S G Ferguson
Journal:  Trends Pharmacol Sci       Date:  2007-03-09       Impact factor: 14.819

Review 3.  Regulation of GPCRs by endocytic membrane trafficking and its potential implications.

Authors:  Aylin C Hanyaloglu; Mark von Zastrow
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

4.  Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex.

Authors:  Valerie M Tesmer; Takeharu Kawano; Aruna Shankaranarayanan; Tohru Kozasa; John J G Tesmer
Journal:  Science       Date:  2005-12-09       Impact factor: 47.728

Review 5.  Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis.

Authors:  Gurpreet K Dhami; Stephen S G Ferguson
Journal:  Pharmacol Ther       Date:  2006-03-06       Impact factor: 12.310

6.  G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton.

Authors:  Sarah H Cant; Julie A Pitcher
Journal:  Mol Biol Cell       Date:  2005-04-20       Impact factor: 4.138

Review 7.  G protein-coupled receptor sorting to endosomes and lysosomes.

Authors:  Adriano Marchese; May M Paing; Brenda R S Temple; JoAnn Trejo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 8.  Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview.

Authors:  Rajiv Tandon; Matcheri S Keshavan; Henry A Nasrallah
Journal:  Schizophr Res       Date:  2008-03       Impact factor: 4.939

9.  Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.

Authors:  Philip Seeman
Journal:  Synapse       Date:  2007-12       Impact factor: 2.562

10.  G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor.

Authors:  Yoon Namkung; Concetta Dipace; Jonathan A Javitch; David R Sibley
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

View more
  39 in total

Review 1.  Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2012-06-01       Impact factor: 4.315

2.  Ligand-induced internalization and recycling of the human neuropeptide Y2 receptor is regulated by its carboxyl-terminal tail.

Authors:  Cornelia Walther; Stefanie Nagel; Luis E Gimenez; Karin Mörl; Vsevolod V Gurevich; Annette G Beck-Sickinger
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

Review 3.  GRK2: multiple roles beyond G protein-coupled receptor desensitization.

Authors:  Tama Evron; Tanya L Daigle; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2012-01-23       Impact factor: 14.819

4.  Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors.

Authors:  Luis E Gimenez; Seunghyi Kook; Sergey A Vishnivetskiy; M Rafiuddin Ahmed; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 5.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

6.  Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins.

Authors:  Sergey A Vishnivetskiy; Luis E Gimenez; Derek J Francis; Susan M Hanson; Wayne L Hubbell; Candice S Klug; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

7.  Growth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2.

Authors:  Zhengyu Wei; Reginald Hurtt; Michele Ciccarelli; Walter J Koch; Cataldo Doria
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

8.  Mutation of three residues in the third intracellular loop of the dopamine D2 receptor creates an internalization-defective receptor.

Authors:  Cecilea C Clayton; Prashant Donthamsetti; Nevin A Lambert; Jonathan A Javitch; Kim A Neve
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

9.  Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission.

Authors:  Tanya L Daigle; Mark J Ferris; Raul R Gainetdinov; Tatyana D Sotnikova; Nikhil M Urs; Sara R Jones; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2014-04-29       Impact factor: 7.853

10.  GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity.

Authors:  Allison Doyle Brackley; Ruben Gomez; Armen N Akopian; Michael A Henry; Nathaniel A Jeske
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.